Browse by ▼

Bio-Reference Laboratories, Inc.

  • Outlook for the Most Shorted Stocks

    By Brian Nichols - May 17, 2013 | Tickers: BRLI, BTH, CSTR, QCOR, SPPI

    When you look at the S&P 500’s most shorted stocks, all are cheap yet short investors continue to bet on lower prices. Therefore, I am looking at the most shorted stocks according to Bespoke Investment Group’s monthly list, to determine if any are a “buy.”

    Company

    Short-Interest vs. Float

    Shares Short (4/30)

    Shares Short (3/30)

    Blyth (NYSE: BTH)

    68.36%

    5.62 million

    5.32 more »

  • 7 Steps to Find Winning Stocks

    By Mark Morelli - May 2, 2013 | Tickers: AAPL, BRLI, SAM, VRTS

    Last year I had a problem. I had taken some profit on part of my investment in Apple and needed somewhere to put the gains.

    I bought three stocks, and two of them enjoyed significant run-ups. I nearly doubled my investment in one of them within six months. The third has dropped slightly.

    Apple had experienced a nice run up over the previous few years (and I had realized a more »

  • Ride the Spending Trends

    By Mark Morelli - January 2, 2013 | Tickers: BRLI, HD, JNJ, WSM

    The average American household had an income of $63,385 and spent $49,705 in 2011. Where did all the money go?

    The following chart shows the portion of total spending by major category as well as the trend observed since 2000 (not adjusted for inflation). The information was compiled by the U.S. Dept. of Labor.

    Category

    Portion of Total Spending (2011)

    Trend (*)

    Annualized Increase (*)

    Housing

    33.8%

    Moderately more »

  • Earnings News: Whole Foods, Qualcomm, and More

    By Mark Morelli - December 8, 2012 | Tickers: BRLI, QCOM, VRTS, WFM

    Here is a review of some earnings announcements made over the past few weeks.

    Bio-Reference Laboratories (NASDAQ: BRLI): The Elmwood Park, NJ based medical testing laboratory is the fourth largest in the country. It has a broad customer base of physician's offices, clinics, hospitals, private companies and some government entities, and there is plenty of room to expand. 

    For the quarter ending Oct. 31, Bio-Reference reported a 16% increase more »

  • 3 Growth Stocks I Bought Last Week

    By Mark Morelli - November 23, 2012 | Tickers: BRLI, SAM, BWLD, PNRA, VRTS

    Most of my new investments over the past few years have been in dividend paying stocks. As I transition to retirement I will need to supplement my pension and part-time work income.

    However, last week I bought three growth stocks to address the other part of my plan to ensure that my portfolio can also reap even higher returns than those typically offered by the stalwart, but relatively slower growth more »

  • Best Companies Under A Billion

    By Mark Morelli - October 30, 2012 | Tickers: BRLI, SAM, BWLD, CRUS, SWI

    Forbes magazine just published an article about the best small, public companies in the U.S. right now. One of the criteria was for current revenue to be less than $1 billion. Included in the story is commentary from Jack Dorsey, founder of Twitter and Square, about the essential challenges that exist for some of them today. You can read the online article here.

    The print version of the story more »

  • The Price is Right at Quest Diagnostics

    By Steve Van - September 12, 2012 | Tickers: BRLI, LH, DGX

    Quest Diagnostics Inc. (NYSE: DGX) and Laboratory Corporation of America (NYSE: LH) are two giants in the diagnostic testing business which is experiencing shifting domestic population demographics, changing laws and regulations, and changing customer preferences.  Another player in the industry is the much smaller Bio-Reference Laboratories Inc. (NASDAQ: BRLI) which operates primarily in metro New York.  Quest's position as the market leader should result in above market returns for more »

  • Quest or Labcorp – How About a Smaller Option?

    By Chad Henage - January 26, 2012 | Tickers: BRLI, LH, DGX

    When most people are asked by their doctor where they would like to go to get their blood drawn or a test done the choices are usually Quest Diagnostics (NYSE: DGX) or Labcorp (NYSE: LH). These two titans of the testing and analysis industry have more locations and are generally well known. In beginning to write this I expected to compare these two and see which looked like the better buy. Then something happened, I realized they have a much smaller competitor that is crushing both of their results. Who is this small fry in the same business? - Bio-Reference Laboratories (NASDAQ: BRLI).

  • BRLI and Tax Loss Harvesting

    By Laurie Frederiksen - December 19, 2011 | Tickers: BRLI

    If you hold shares in Bio Reference Labs (NASDAQ:BRLI), you might have an ideal set of circumstances to consider some tax loss selling.